HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CAV regimen

a chemotherapy protocol consisting of the above compounds; used for the treatment of patients with Hodgkin's disease

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - CAV regimen: 3
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - CAV regimen: 3
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - CAV regimen: 3
Organic Chemicals: 133
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - Tetrahydronaphthalenes: 1
      - Podophyllotoxin: 562
        Etoposide: 10706
        CAV regimen: 3
Carbohydrates: 22023
- Glycosides: 2119
  - Glucosides: 639
    - Etoposide: 10706
      - CAV regimen: 3
Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Cyclic Amino Acids: 3
    - Aromatic Amino Acids: 467
      - Phenylalanine: 4090
        Melphalan: 4353
        CAV regimen: 3

Experts

1.	Anderson, H: 1 article (08/2001)
2.	Arance, A: 1 article (08/2001)
3.	Burt, P A: 1 article (08/2001)
4.	Lorigan, P: 1 article (08/2001)
5.	Middleton, M R: 1 article (08/2001)
6.	Stout, R: 1 article (08/2001)
7.	Summers, Y: 1 article (08/2001)
8.	Thatcher, N: 1 article (08/2001)
9.	Valle, J: 1 article (08/2001)
10.	White, S C: 1 article (08/2001)

Related Diseases

1.	Cardiotoxicity 04/01/1989 - "Similarly, the substitution of etoposide for the doxorubicin in the CAV regimen was associated with prolonged survival and reduced cardiotoxicity."
2.	Neutropenia 08/01/2001 - "Grade 3-4 neutropenia and intravenous antibiotic use were significantly more common with the CAV regimen (P < 0.005). "
3.	Hodgkin Disease (Hodgkin's Disease) 05/01/1994 - "Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease."

Related Drugs and Biologics

1.	Etoposide (VP 16)
2.	Melphalan (Alkeran)
3.	Lomustine (CCNU)
4.	Doxorubicin (Adriamycin)
5.	Anti-Bacterial Agents (Antibiotics)

Related Therapies and Procedures

1.	Salvage Therapy